Human Angiotensinogen quantitates human Angiotensinogen in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Angiotensinogen.
Accession number
Agt ; AI265500 ; alpha-1 antiprotéinase, antitrypsine ; Ang ; Ang I ; Ang II ; Ang III ; Ang IV ; AngI ; AngII ; angiotensine 1-10 ; angiotensine 1-4 ; angiotensine 1-5 ; angiotensine 1-7 ; angiotensine 1-8 ; angiotensine 1-9 ; angiotensine 2-8 ; angiotensine 3-8 ; angiotensine I ; angiotensine II ; angiotensine III ; angiotensine IV ; angiotensine ll ; angiotensine-1 ; angiotensine-2 ; angiotensine-3 ; angiotensine-4 ; angiotensinogène ; angiotensinogène (PAT) ; angiotensinogène (inhibiteur de la peptidase de serpine, clade A, membre 8) ; ANHU ; ANRT ; Aogen ; Des-Asp[1]-angiotensine II ; PAT ; pré-angiotensinogène ; inhibiteur de protéinase de sérine (ou cystéine) ; serpine A8 ; inhibiteur de peptidase de serpine, clade A, membre 8 ; SERPINA8
Dose range
1.22 to 300 ng/ml
Sensitivity of the dosage
1.22 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human Angiotensinogen quantitates human Angiotensinogen in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Angiotensinogen.
Human Angiotensinogen quantitates human Angiotensinogen in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Angiotensinogen.
The protein encoded by the pre-angiotensinogen or angiotensinogen, AGT, is expressed in the liver and is cleaved by enzymatic renin in response to a decrease in blood pressure. The resulting product, "?angiotensin I, is then cleaved by the l-angiotensin conversion enzyme (ACE) to generate the active physiological enzyme, l-angiotensin II. The protein is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Mutations of this gene are associated with sensitivity to essential hypertension and may cause renal tubular dysgenesis, a serious renal tubular development disorder. Defects in this gene have also been associated with non-family structural atrial fibrillation and chronic inflammatory bowel disease.
Sensitivity
Sensitivity of the dosage: 1.22 ng/ml.
Measurement range
Dose range: 1.22 to 300 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Angiotensinogen.
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17154583
Specifications
Accession number
Agt; AI265500; alpha-1 antiproteinase, antitrypsin; Ang; Ang I; Ang II; Ang III; Ang IV; Ango ; AngII ; angiotensin 1-10 ; angiotensin 1-4 ; angiotensin 1-5 ; angiotensin 1-7 ; angiotensin 1-8 ; angiotensin 1-9 ; angiotensin 2-8 ; angiotensin 3-8 ; angiotensin I ; angiotensin II ;